PF

Pathrose Florence

Director Director DIN 06818610
DIN 06818610 First appointment Feb 2014 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2014
Shareholding value •••• Premium profile

About Pathrose Florence

Data last updated:

Pathrose Florence was a Director at Anugragha Nidhi Limited (2014–2015) and Director at Newallegrow Biotech India Limited (2014–2015). The companies operate in Financial Services and Real Estate.

DIN 06818610
Primary Designation Director
Industry Financial Services
First Appointment 24 Feb 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anugragha Nidhi Limited U65993TN2014PLC098541
Director22 Dec 20142014Active
Newallegrow Biotech India Limited U70200TN2014PLC095174
Director24 Feb 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Anugragha Nidhi Limited
Newallegrow Biotech India Limited
Premium access

Shareholding and investment profile for Pathrose Florence

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pathrose Florence

Pathrose Florence was first appointed on 24 Feb 2014 as Director at Newallegrow Biotech India Limited.

Pathrose Florence held 2 earlier board appointments: Anugragha Nidhi Limited (Director, 22 Dec 2014 to 24 Sep 2015); Newallegrow Biotech India Limited (Director, 24 Feb 2014 to 09 Mar 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available